BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.88
-0.24 (-0.39%)
At close: Mar 9, 2026, 4:00 PM EDT
61.00
+0.12 (0.20%)
After-hours: Mar 9, 2026, 7:51 PM EDT
BioMarin Pharmaceutical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 348.9 | 426.86 | 167.65 | 141.56 | -64.08 | Upgrade
|
| Depreciation & Amortization | 72.16 | 96.43 | 104.39 | 101.97 | 108.04 | Upgrade
|
| Other Amortization | 7.4 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -10 | - | -108 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 345.98 | 19.89 | 38.61 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.8 | -8.35 | -9.23 | 3.04 | 5.16 | Upgrade
|
| Stock-Based Compensation | 181.41 | 201.57 | 207.1 | 196.31 | 197.26 | Upgrade
|
| Other Operating Activities | 170.61 | 62.84 | -12.71 | -62.6 | -7.88 | Upgrade
|
| Change in Accounts Receivable | -228.05 | -57.91 | -190.44 | -82.03 | 65.57 | Upgrade
|
| Change in Inventory | -116.93 | -63.53 | -157.06 | -68.26 | -35.06 | Upgrade
|
| Change in Accounts Payable | 66.14 | -32.24 | 68.85 | 59.02 | 15.69 | Upgrade
|
| Change in Other Net Operating Assets | -14.81 | -62.72 | -57.9 | -5.1 | 19.83 | Upgrade
|
| Operating Cash Flow | 827.99 | 572.84 | 159.26 | 175.9 | 304.54 | Upgrade
|
| Operating Cash Flow Growth | 44.54% | 259.69% | -9.46% | -42.24% | 256.75% | Upgrade
|
| Capital Expenditures | -103.04 | -85.42 | -96.69 | -120.96 | -95.58 | Upgrade
|
| Cash Acquisitions | -285.19 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -7.94 | -1.99 | -10.92 | 92.74 | -23.65 | Upgrade
|
| Investment in Securities | -18.07 | 222.77 | -3.63 | 8.19 | -246.09 | Upgrade
|
| Other Investing Activities | - | 1.14 | - | - | -0.99 | Upgrade
|
| Investing Cash Flow | -414.24 | 136.49 | -111.24 | -20.03 | -366.31 | Upgrade
|
| Long-Term Debt Repaid | - | -494.99 | - | - | -3.04 | Upgrade
|
| Net Debt Issued (Repaid) | - | -494.99 | - | - | -3.04 | Upgrade
|
| Issuance of Common Stock | 14.46 | 49.28 | 69.35 | 69.33 | 49.19 | Upgrade
|
| Repurchase of Common Stock | -55.97 | -77.56 | -76.32 | -54.28 | -45.81 | Upgrade
|
| Other Financing Activities | -0.89 | -3.18 | -11.76 | -33.7 | -0.4 | Upgrade
|
| Financing Cash Flow | -42.39 | -526.45 | -18.73 | -18.65 | -0.05 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.52 | 4.83 | 1.31 | 0.03 | -0.06 | Upgrade
|
| Net Cash Flow | 368.84 | 187.72 | 30.6 | 137.26 | -61.88 | Upgrade
|
| Free Cash Flow | 724.96 | 487.42 | 62.57 | 54.94 | 208.96 | Upgrade
|
| Free Cash Flow Growth | 48.73% | 679.02% | 13.88% | -73.71% | - | Upgrade
|
| Free Cash Flow Margin | 22.50% | 17.08% | 2.59% | 2.62% | 11.32% | Upgrade
|
| Free Cash Flow Per Share | 3.67 | 2.48 | 0.33 | 0.29 | 1.14 | Upgrade
|
| Cash Interest Paid | 7.25 | 10.36 | 10.3 | 10.28 | 10.4 | Upgrade
|
| Cash Income Tax Paid | 96.21 | 57.27 | 73.31 | 54.37 | 18.15 | Upgrade
|
| Levered Free Cash Flow | 402.66 | 212.05 | -148.78 | 137.32 | 201.61 | Upgrade
|
| Unlevered Free Cash Flow | 409.47 | 219.97 | -137.94 | 147.3 | 211.19 | Upgrade
|
| Change in Working Capital | -293.66 | -216.4 | -336.54 | -96.38 | 66.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.